Introduction
The past decades' alleged 'war(s) on cancer' -reflected in massive financial flows, biotechnological innovations and changes in the organization of interventions and practices -have proven still more efficient leaving in its wake increasing cancer survival rates and the potential spread of 'survivor narratives' in Denmark as well as in other parts of the Global North (Rubin et al., 2015) . In many ways, these changes may encourage us to think that we are entering a new social and cultural history of cancer that will eventually challenge notions of cancer as a signifier of death and degeneration, so poignantly discussed by Sontag (Sontag, 1983 (Sontag, (1978 ), as well as cancer's impact on individual and social lives. Concerted efforts to increase survival rates does, however, not only manifest in a multiplicity of meanings and associations attached to experiencing or dying from cancer. Rephrasing Paul Stoller, this paper suggests that ongoing changes in orientations to cancer disease control equally extend into 'the village of the healthy' as into 'the village of the sick ' (2005) .
Changes in the social and cultural history of cancer in Denmark and the Global
North are characterized by changes in the orientation toward cancer disease control, where a focus on early diagnosis has been added to an already firmly established prevention discourse, or what Tørring (2014) has referred to as a reconceptualization of cancer as an acute disease 1 . During the past decade Denmark has witnessed an unprecedented transformation in the rationales underpinning cancer diagnostics (cf. . According to Tørring (2014) these shifts arose not only due to the interests of health promoters but were also made possible as a result of the intricate relationship that exists between collective cancer imaginaries, fears and available resources. Tørring (2014:15) suggests, for example, that the booming economy of the early twenty-first century, as well as a general politics of fear, made the introduction of early cancer diagnosis possible as it required a radical change in resource distribution. This paper expands on Tørring's cultural analysis of contemporary orientations toward cancer disease control; not by reflecting on its preconditions, but more on how biomedical knowledge production potentially extends its boundaries into everyday social life. Overall, the paper suggests that the emphasis on early diagnosis of cancer aligns ideas on a symptomatic management of the public with a process in which 'what counts as cancer symptoms' is steadily being subdivided, classified and expanded. The paper suggests that inquiries into the production of symptom categories may provide potential insights into the intricate relations between biomedical knowledge production and embodied experience, and in particular how biomedicine adds to the building of what Kleinman and Fitz-Henry (2009) have tentatively referred to as the building of contemporary forms of disease sensitization -here defined as a form of embodied subjunctivity (Whyte, 2005) characterized by the potential or the ever-present 'what if' brought on by our human desire to alleviate or prevent suffering disease.
The first part of the paper illustrates how a symptom management of the public has gained a powerful presence in contemporary orientations to cancer disease control. A presence which adds to a medical semiotics (Good, 1994) that directs awareness to the tangible, perceptible body and its cancer potentials; Is this tiredness a sign of disease? What should I think about my weight loss? It is suggested that a technologisation of biomedical practice such as exemplified by orientations to cancer diagnostics is increasingly tied up to sensorial experience. This leads to the second part of the paper, which contributes to an emergent critical literature on symptom experiences (cf. Hay, 2008; Risør, 2011 , Hinton & Hinton, 2002 .
Anthropologists have for long been interested in the ways individuals ascribe meaning to symptom experiences, but only recently have this interest translated into more theoretical clarifications on how symptom experiences evolve in cycles of experience and articulation encompassing both individual and shared sensory categories. With few exceptions (cf. Lock, 1993; Hinton and Hinton, 2002; Kirmayer, 1992) , anthropological research on symptom experiences have been occupied with their place in the narrative construction of illness experiences (cf. Garro, 1998) or their moral value and relation to bodily management or decision-making (cf. Hunt, 1998) . Less focus has been directed to questions such as; How are bodily sensations experienced and articulated in the first place, and how or when they are directed towards the realm of illness?
Foucaultian inspired scholarship has done pioneering work on the reciprocal flow between power relations and 'the social domain' illustrating the productive forces of biopower in shaping the micro-politics of bodily management and perception (cf. Lock, 1993; Rose, 2007) . It is thus well established that the body is both a biological phenomenon as well as a cultural product, and that discourse is 'part and parcel of processes of embodiment and sense-making' (Porcello et al., 2010:61) . As noted by several scholars, it is the tracing out of the complex relations between these domains -or the tracing out of how biopower(s) become productive in the configuring of embodied experience -that is the remaining, ongoing project (Whyte, 2009; Porcello et al., 2010) . Following the work of Hinton (2002 Hinton ( , 2008 and Geurts (2002) along with others (e.g. Nichter, 2008; Hay, 2008) this paper suggest that integrating research on sensorial experience with critical writings on discourse and biopower is one way to more fully articulate relations between biomedical knowledge and bodily experience; thus allowing us to 'do this tracking'. Following the proposition presented that our sensorium, defined as the bases of our perception and the seat of embodied sensation, is historically and socially constituted (Geurts, 2002) , the paper thus echoes ongoing calls to explore symptom experiences as cultural configurations of sensation experience. Following Cameron Hay (2008) this may be epitomized as:
A sensation is embodied; it is felt experience. By contrast, a symptom is a constructed and socially informed cognitive interpretation that indexes but is not itself an embodied sensation (Ibid.: 221) .
The argument presented is thus somewhat similar to critical approaches to the study of diagnostic categories as deep-seated, cultural assumptions about what it means to know the body, which sociologists and anthropologists have explored for the past decades (cf. Lock, 1993; Young, 1995) . The production of diagnostic categories -it is well established -opens up new spaces for the production and articulation of different forms of distress and also shapes embodied experience. In the same way, approaching the production of symptom categories and exploring the connections between biomedical knowledge production and everyday embodied experience may lead to an understanding of the social and moral values placed on embodied sensations that 'shape that nascent zone, where sensation becomes conscious experience and undergoes a transformation to symptom' (Hinton and Hinton, 2002: 157) .
Methods

I have been affiliated with the Research Centre for Cancer Diagnosis in Primary
Care at Aarhus University since its establishment by Danish epidemiologist Peter Vedsted in 2010. The commitment to the reflections brought forward in the paper is the result of yearlong research efforts exploring why and when people seek medical assistance (cf. Andersen, et al., 2010) as well as the centre's collective endeavours to critically study public health-related subjects such as delay in diagnosis and awareness (cf. Merrild, et al., 2016; Offersen, et al. 2017; Andersen & Risør, 2014) . The analysis presented is the result of ongoing fieldwork I conducted on Danish general practice as part of a cancer research environment as well as my access to epidemiological research environments; talks and discussions on clinical practice with colleagues working as doctors or in public health. Fieldwork has been reported elsewhere (cf. Andersen, Tørring, & Vedsted, 2014) .
Directing sensations in contemporary medicine
For the past decade Rose (2007) , among others, has argued that we live in an age where biomedicine is redirecting the attention of our corporal existence to its diminutive parts, to the molecular level of existence, encouraging us to engage with, experience and imagine our bodies in particular ways. (Ibid.:26) .
In accordance with this line of thought Howes and Classen (2014) describe how the introduction of biotechnology has reduced the medical and clinical reality to that which meets the eye, suggesting that 'the recording and communication of patient sensations' (Ibid.:48) has become of still less importance to the everyday practice of medicine.
The corporeal re-direction or attention to the molecular level is also reflected in the search for the early cancerous body. In Denmark, pre-symptomatic cancer prevention practices, such as genetic counselling, is available for selected risk groups, defined by objectified knowledge on cancer heredity (e.g. BRCA-1 gene and risk of breast cancer) (cf. Svendsen, 2005) . Moreover, during the past decade we have witnessed the introduction of a wide range of biomarkers (e.g. prostatespecific antigen) into clinical use. When I argue for a re-direction to the tactile body to sensations and their potential transformation into symptom experiences, it may thus appear as an appeal to engage with a topic from the past and of which techno-medicine, to stay with the terminology of Rose (2007:11) , has lost interest.
I will argue, however, that restraining ourselves to explore how biomedicine narrates disease at the molecular level is too narrow to achieve an understanding of the potential social implications of cancer disease control.
Despite its biotechnological alignments, cancer diagnostics is infinitely symptom based, which means that healthcare trajectories and the organisation of clinical practices depends on the categorisation and interpretation of the perceptible, tangible body and the translation (or redirection) of embodied sensations into potential symptoms of disease. Approximately 90% of all cancers diagnosed in Denmark begin with an individual's response to an embodied sensation and a decision to seek medical assistance, having to answer questions such as: Where does it hurt? What are your symptoms? As will be developed on in the below, an emphasis on symptom experiences as a way to manage cancer disease control forces an alignment with the senses, as it changes the social and moral values placed on bodily sensations such as tiredness, pains, a bloated stomach or those vague and intermittent, difficult-to-verbalise kinds of sensorial experiences that may be part of our everyday embodied ways of being-in-the world.
Identifying the cancerous body
The reconceptualisation of cancer as an acute disease is a telling example of complex intertwining in action and can be viewed as a configuration of biological, sociological and epidemiological styles of thought (Hacking, 1990) . Its reconceptualisation ties, for example, thoughts concerning exponential tumour growth and a moving towards death, with sociological ideas that affect the conduct of individuals and organisations, both bridged by epidemiological efforts to delineate with ever more accuracy 'the early symptoms' of cancer. In Denmark, this configuration is visible in the implementation of biotechnological innovations and increasing access to MR and CT scanners, which permit early detection of tumours and socio-politically enforced changes in the organisation of healthcare delivery. Since 2007 the Danish healthcare system has witnessed the implementation of more than 30 standardised cancer pathways, and Danish hospitals have invested a vast amount of resources to eliminate waiting times and to improve the organisation of diagnostic investigations (Probst, Hussain & Andersen, 2012) . In the process of managing the public and implementing and administering the organisation of diagnostic practices, cancer symptoms have gained a powerful symbolic presence. The clinical guidelines on cancer pathways list, together with other forms of objectified clinical knowledge, such as age and smoking status, various symptoms which are used to sort patients when they access the healthcare system. The cancer pathway for ovarian cancer, for example, states that bodily sensations such as abdominal bloating, nausea, lack of appetite, frequent urination, obstipation and tiredness should raise the suspicion of ovarian cancer and warrant a referral to a diagnostic fast-track pathway (Danish Health Authority, 2012).
Moreover, the Danish health authorities, as well as major patient organisations (e.g. The Danish Cancer Society) have launched national campaigns aimed at raising people's awareness of cancer symptoms and advocate seeking healthcare early. In the Danish Cancer Society's most recent national campaign, 'Know the seven signs', the public is encouraged to seek medical advice if experiencing prolonged coughing, unexplained weight loss, unexplained bleeding, changes in birthmarks, lumps, difficulties swallowing and changes in bowel movements (Danish Cancer Society 2015) . In the material each symptom is described in detail, followed by visual images of ticking clocks and doctors announcing the importance of not delaying to take action. In a TV campaign the powerful and disastrous relation between the acuteness of cancer, lack of awareness and time-passing-by is portrayed in a sequence, where a man silently rests in a chair in front of his TV while not noticing that his house is catching fire. The overall message of the images and statements thus emphasise the dangers associated with failure to respond to (as well as recognise) embodied sensations as potential signs of a malignant disease.
Reference to symptom categories has thus gained a powerful symbolic presence in managing and reorganising cancer disease control in Denmark; objectified as abstract-able forms of body-knowledge that may propel people -the potential patients as well as health professionals -to consider whether a serious disease might be lurking in the(ir) body. Equally interesting is the fact that the presentation of cancer symptoms in public health rhetoric and clinical guidelines appears to build on a presumed capacity of epidemiological knowledge to form a new 'know how' that will ensure early diagnosis of cancer. In further underlining the importance of attending to symptoms I will go on to discuss what constitutes this 'know how'.
In particular, I argue that cancer symptom categories can be understood as what Lock and Nguyen (2010:18) call techno-phenomena, in the sense that they are unstable, objectified forms of knowledge that configure in the interface 'between available technologies, clinical practices and preconditioned ways of seeing and understanding' (Ibid.). This is not to dispute that cancer or tumour growth is a biological phenomenon. Bodies harbour tumours that grow in size and produce altered physiological states that will at some point produce, for example aches and pains, bleeding or lumps that require attention, and tumours can cause death and suffering. But the question is how aches and pains end up being articulated as symptoms of cancer.
The search for early symptoms
As Aronowits (2007) notes in his exploration of the social history of breast cancer, there was a remarkable stability throughout the twentieth century in what was considered the core list of cancer danger signs. For centuries the public was taught to respond to lumps or blood and to what was considered vaguer signs, for instance, 'a sore that does not heal, blood in stool or chronic indigestion' (Ibid.:145-146).
Clinical or scientific reference to the alarming symptoms of cancer is thus not of recent origin, but systematic epidemiological interest in identifying early cancer symptoms began just a decade ago. The most influential, widespread studies are based on epidemiological research and are applied in clinical, general practice medicine (Hamilton, 2009; Jones, et al., 2007) 2 . In this literature alarm symptoms are defined as 'symptoms that are associated with a subsequently greatly elevated risk of serious disease being identified' (Ibid.:1). There is no consensus in clinical and epidemiological research, however, on the definition of 'a greatly elevated risk'. Moreover, the composition of contemporary categories of alarm symptoms does not transcend time and space. On the contrary, following Lock's (1993: xviii) reasoning on the factuality of menopause, we may see that it is a category 'with boundaries and meanings that shift depending upon the viewpoint and interests of speaker and listener'.
Contemporary scientific language on the classification of alarm symptoms of cancer is based on probability theory and developed to provide quantified probabilities on the risk of having a particular cancer disease when experiencing a specific bodily sensation. Apart from lumps, the majority of bodily sensations referred to as alarming in contemporary guidelines or campaigns (such as abdominal pain, changes in dietary habits, haemoptysis, cough and rectal bleeding)
have estimated predictive values of approximately 0.4-5.0% among individuals who have sought medical advice. While risks estimates increase with age and with the presence of more symptoms, overall, the risk values presented in the epidemiological literature are quite low (Hamilton, 2009) . From a semiotic perspective, this may prove troublesome as it makes distinguishing between normal and pathological signs difficult, that is 'symptoms' are iconic and can be interpreted widely (cf. Good, 1994; Hinton & Hinton, 2002) . Among clinicians and in clinically oriented research this has spurred debate and concern on how to identify the potentially cancerous body from the non-sick bodies. From an epidemiological research perspective, low risk estimates, however fed into more reckonable discussions on what should be considered alarming: When a person present with symptoms indicating a two percent risk? Or a five percent risk? Initially, leading epidemiologists suggested pursuing a five percent risk strategy (Jones et al., 2007) ;
meaning that people presenting in general practice clinics with symptoms indicating a five percent risk of cancer should undergo diagnostic investigations. In the past five or six years, however, and as the reconceptualisation of cancer as an acute disease has gained political and public momentum, a more ideological position centring on the logic of urgency is taken, suggesting that the lower the threshold, the greater the probability of not overseeing a cancer diagnosis. Various examples of this exist in the UK and Denmark, which play a leading role in re-orienting cancer disease control in the Global North.
In the UK, two-week-wait national guidelines were implemented as early as the beginning of this century. Driven by attempts to further improve cancer pro- what has been referred to as unspecific or low-risk, but not no-risk, symptoms (Hamilton, 2009:441) .
In Denmark diagnostic pathway subdivisions are not fully implemented, but research projects identifying the unspecific and low-risk-but-not-no-risk symptoms of diverse cancers have been initiated and early diagnosis advocates believe their implementation is will soon be underway. Importantly, ongoing debates about cancer diagnostics and low-risk-but-not-no-risk symptoms illustrate how identified flaws in cancer disease control are often met with further subdivisions and, of greater importance, how epidemiological fervour for classification results in a process where still more bodily sensations are transformed into potential symptoms of cancer. Hamilton et al. (2009) refer to a number of bodily changes such as constipation, tiredness or diarrhoea as low-risk-but-not-no-risk symptoms that should warrant investigation. Changes which, as also stated 'when presented in general practices have 1% risk of having a cancer, but in a population who has not sought care is much, much lower' (Hamilton, 2009: x) cancer symptoms reflects a scientific approach to the body that offers an extremely partial picture, 'pushing to the extremes the forensic aspects of certainty, and trying to extend the certainty-seeking practices of science'. In a search for certainty in terms of being certain to identify the early cancerous body, and in a search to identify the early cancer symptoms enabling the identification of the cancerous body, the epidemiologically-driven introduction of low-risk-but-not-no-risk symptoms is a process where what counts as cancer symptoms is steadily being subdivided, classified and, not least, expanded.
Technology and treatment imaginaries
In her exploration of cancer narratives in the oncology ward, Delvecchio-Good (2001) argues that the presence of increasingly complex and innovative forms of biotechnology spark hope and treatment imaginaries that manifest in certain affective and economic flows, together establishing what she calls a biotechnical embrace, and which she sees manifest in the ways patients and oncologists narrate cancer disease trajectories in the US healthcare system. Increasing access to complex forms of biotechnology also plays a vital part in reorganising cancer disease control in the Danish setting. In this section, and in order to initiate reflections on cancer and disease sensitisation, I explore how the joining of the logic of urgency and increasing access to biotechnology 'sparks hope and treatment imaginaries' (Ibid.:397), but also adds a particular dimension of uncertainty to the classification and subdivision of symptom categories described above.
The introduction of magnetic resonance imaging (MRI) scanners in 1984 was
an obvious influence preconditioning early diagnosis initiatives in Denmark.
Since then, numerous other high-tech diagnostic tools have been introduced, allowing for still more detailed, easy access to bodily introspection. Computerised tomography (CT) scanners and access to digital imaging technologies have, for example, altered diagnostic potential for lung cancers in Denmark (Guldbrandt et al., 2015) , and the introduction of capsule endoscopy is expected to lead to ear- 
Symptoms as cultural configurations
In the final part of the paper I will briefly illustrate ways in which a medical anthropology of the senses can contribute to the study of symptom experiences and provide insights into the relations between biomedical knowledge production and embodied experience (cf. Andersen, Risør & Nichter, 2017) . This section should merely be read a proposition for future research, not as a fully developed analysis of the social implications of contemporary orientations to cancer diagnostics such as explicated in the above.
In a special issue of Transcultural Psychiatry Hinton and Kirmayer (Hinton et al., 2008) together with Nichter (2008) and others (Hay, 2008 ) embarked on presenting an agenda to explore the relevance of the senses to medical anthropology. While this brief excerpt on Marianne's encounter with her doctor, Thomas, does not allow us to reflect in detail on the social processes through which she came to experience her body as potentially hiding a cancer, it does, however, accentuate the relevance of turning to symptom experiences as cultural configurations of sensorial experience.
In the medical literature symptoms have traditionally been defined as patients' subjective illness worries or presentations. WONCA, the international organization for general practitioners (GPs) and family physicians, for example, presented in 1995 an international glossary for general practice where a symptom was defined as '…any expression of a disturbed function or structure of the body and mind by a patient. Cough, pain, and tiredness are symptoms' (Bentzen, 1995:133) . Following this line of reflection, the reference to cancer by Marianne may be viewed as her subjective way of interpreting her symptoms; she experiences symptoms and interprets them as potential signs of cancer. Taking a sensorial approach, we are, however, encouraged to ask, why or how she came to attend to her feeling heavy as 'a disturbed function', or how this 'disturbed function' was processed in the first place. In this sense Marianne's symptom experiences are not just expressions of her subjective concerns of a 'disturbed function', nor are they mere parts of an ongoing illness narrative through which she gives meaning to existing sufferings. Rather, we may hypothesize that Marianne's embodied experiences and her way of being attentive to her body and providing meaning to the 'heaviness in her lower parts' configures in the intersection between her everyday life-world;
through engaging with friends and family and through her/their encounters with contemporary biomedical discourse on cancer disease control. In order to emphasize this point, let us briefly jump to another ethnographic location. As noted by Julie Livingston (2012) Africa (2012:33) .
As suggested here, contemporary changes in the social and cultural history of cancer in Denmark do in many ways resemble the opposite of Livingstone's Botswana. In Botswana, we may imagine how people are taught endurance or 'bodily ignorance'. While in Denmark the public is encouraged to be vigilant, aware and respond with urgency if they sense even the slightest change in their bodies, as this is the cocktail that may change (or revert) cancer prognostic horizons.
But how may we understand such differences? Imagine Marianne in Botswana;
would she simply have ignored the 'heaviness in her stomach'? Thinking that no doctor would be able to help her? Or would she not even have experienced it? That is, would 'the heaviness' not have stood out from the everyday passive endurance of embodied existence 'as something to pay attention to'? Or would it simply not have been there? We do not know. Taking the proposition by Hinton (2002 Hinton ( , 2008 , Geurts (2002) and other sensorially oriented scholars seriously, we are, however, 
Disease sensitisation
According to Merriam-Webster's Dictionary, 'sensitisation' is 'the process of becoming highly sensitive to specific events or situations' and, more specifically in reference to medicine, it means being more sensitive towards 'a specific serum ' (Merriam-Webster, 20 November, 2016) . Disease sensitisation, I, however, suggest, may refer to an embodied form of being; a form of being where one is sensitive towards ideas, connotations or signs of disease. Conceptually, it goes beyond an ordinary understanding of awareness, which often refers to the more cognitive process of linking knowledge and experience (Good, 1994) , and it also departs from ideas concerning pathologisation, which refers to feeling sick or diseased (Conrad, 2007:11-12) . Rather, disease sensitisation, this paper suggests, refers to an embodied form of experience, reflecting on the 'what if', and where sensation meaning and experience is produced in a social context where disease prevention is invested with great cultural significance (cf. Offersen et al, 2016) . There is thus an intriguing parallel to contemporary theorizing about the subjunctive mood, such as for example presented by Susan Whyte (2005:251) . Subjunctivity, according to Whyte, is that mood of a verb used to express supposition, desire, hypothesis and possibility rather than to state an actual fact. It is distinguished from indicative, imperative which is the voice of certainty. In Whyte's work on the Ngyole in Uganda the subjunctive mood is one of hope, doubt and potential, and is often expressed as the possibility that healing practices, such as a ritual, might alleviate suffering. She describes this as the practicing of healthcare in the subjunctive mood.
In this paper, disease sensitisation is not necessarily related to a particular kind of practice. Rather, I suggest it may be seen as a form of embodied subjunctivity, characterised by the potential, or the ever-present 'what if' brought on by our contemporary desire to alleviate or prevent suffering, such as exemplified in the above presented discussion on cancer disease control. As we learned through our brief encounter with Marianne, it was her socially required knowledge on cancer risks, her mutual hope of 'being early' and her fear of cancer that organized her bodily attention as well as gave meaning to her experiences. But it was not stable meaning, in the sense that there was just one reading of her 'feeling heavy'; it was an embodied form of subjunctivity organized and produced by the uncertain and cultural significance placed on contemporary diagnostic practices. Access to biotechnology and a resourceful socio-political setting keen on winning the war on cancer, thus aligns with the senses by changing the social and moral landscape in which sensations are produced and experienced.
Future, sensorially engaged research is suitable for studying such social change, and for asking how or why contemporary forms of disease sensitisation make more and more people adopt risk roles (Frumer, n.d.) ; explore social differences in how people negotiate access to care (Merrild et al., 2016) or narrate everyday forms of embodiment and reflect on 'am I fine or sick'? (Offersen et al., 2017; Hay, 2008) . Moreover, future research will provide us with more insights into how the building of disease sensitisation will change or revert the prognostic horizons of some, lead others to over-diagnosis, or challenge the allocation of resources due to increasing pressure on the healthcare system.
Conclusion
In this paper I have highlighted ongoing changes in orientations to cancer disease control, particularly health promoter attempts to identify the early cance-rous body in Denmark and the UK. The paper suggests that the emphasis on early diagnosis of cancer aligns ideas on a symptomatic management of the public with a process in which 'what counts as cancer symptoms' is steadily being subdivided, classified and expanded. This alignment, the paper suggests, is an example of how biomedicine potentially extends its boundaries into everyday forms of embodied, social life by changing the social and moral value placed on bodily sensations.
Moreover, the paper echoes ongoing conversations in medical anthropology on symptom experiences; suggesting that symptom experiences may be a suitable analytic axiom for exploring the relationship between biomedical knowledge production and embodied experience. Exemplified by reference to cancer, the paper encourages explorations into the production of symptom categories, not merely, however, as discursive cultural categories providing meaning to embodied experiences, but as a cultural production that may feed into existing cultural order of sensations. Lastly, I outlined an anthropology of sensations as a framework for understanding symptoms as cultural configurations and briefly illustrated its utility for exploring more overall relations between biomedical knowledge production and everyday, embodied experience and the building of contemporary forms of disease sensitisation. of those given the option of a CT scan) is encouraged to do follow-up scans for up to two years after their initial diagnostic investigation (Guldbrandt et al., 2015) . 7 Conversations on human sense-modals date back to Aristotle and his presentation of the five-sense-modal. See Geurts (2002:5-7) for detailed discussions of this, and why the 'five-sense-model' should not be regarded a scientific or even relevant cultural model for our understanding of the senses. 
